| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Complete Medical Communications is a Horsham, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
4 Better Sleep is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kerr Drug recognizes that, for most of our customers, convenient access to products and services is a critical issue. That is why we go the extra mile to insure that our customers have the largest selection of things they need - everyday.
Carotech is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.